Combination therapy in hormone-refractory prostate cancer

被引：0
|
作者：
Daniel P. Petrylak
机构：
来源：
Current Oncology Reports | 2001年 / 3卷 / 5期
关键词：
Prostate Cancer; Hydrocortisone; Docetaxel; Mitoxantrone; Estramustine;
D O I：
10.1007/s11912-001-0033-4
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：453 / 453
相关论文
共 50 条
  • [1] Which drug combination for hormone-refractory prostate cancer
    Doggrell, SA
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (04) : 667 - 670
  • [2] Therapy of hormone-refractory prostate cancer
    Heidenreich, A
    UROLOGE, 2005, 44 (12): : 1481 - 1494
  • [3] Hormone-refractory prostate cancer
    Alexandre, I.
    Rixe, O.
    ANNALES D UROLOGIE, 2007, 41 (02) : 47 - 55
  • [4] Chemotherapy in hormone-refractory prostate cancer
    de Wit, Ronald
    BJU INTERNATIONAL, 2008, 101 : 11 - 15
  • [5] Hormone-Refractory prostate cancer
    Rini B.I.
    Small E.J.
    Current Treatment Options in Oncology, 2002, 3 (5) : 437 - 446
  • [6] Significance of docetaxel in the chemotherapy of hormone-refractory prostate cancer
    Wolff, JM
    ONKOLOGIE, 2003, 26 : 37 - 40
  • [7] Combination of epirubicin and cisplatin in hormone-refractory metastatic prostate cancer
    Huan, SD
    Stewart, DJ
    Aitken, SE
    Segal, R
    Yau, JC
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (05): : 471 - 474
  • [8] Treatment options for hormone-refractory prostate cancer
    Heidenreich, A
    Ohlmann, CH
    UROLOGE, 2005, 44 (11): : 1303 - +
  • [9] DocetaxelIn Hormone-Refractory Metastatic Prostate Cancer
    Kate McKeage
    Susan J. Keam
    Drugs, 2005, 65 : 2287 - 2294
  • [10] Docetaxel in Combination with Prednisolone for Hormone Refractory Prostate Cancer
    Ide, Hiroki
    Kikuchi, Eiji
    Kono, Hidaka
    Nagata, Hirohiko
    Miyajima, Akira
    Nakagawa, Ken
    Ohigashi, Takashi
    Nakashima, Jun
    Oya, Mototsugu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (01) : 79 - 84
12345